The Ontario government, in consultation with the Chief Medical Officer of Health, has released A Plan to Safely Reopen Ontario and Manage COVID-19 for the Long-Term, which outlines the province’s gradual approach to lifting remaining public health and workplace safety measures by March 2022. - For Details please visit: Ontario Releases Plan to Safely Reopen Ontario and Manage COVID-19 for the Long-Term. The Grey Bruce Health Unit will provide any local information regarding this announcement as available.

* Vaccine Information and Clinic Schedule

* Children, Youth and COVID-19 Vaccines                        

* Third Dose Vaccine Rollout in Grey Bruce for Certain Immunocompromised Patients

* Proof of Vaccination in Select Settings

Electronic/Printable Vaccine Receipt

* Ontario is currently in Step Three of the Roadmap to Reopen

* Sexual health clinics are closed temporarily. If you need birth control prescriptions or STI testing, go to nearest emergency room. For condoms, visit our office during regular hours.

Latest News Releases

 

21

Expanded Eligibility for Third Doses of the COVID-19 Vaccine

posted on

GBHU Logo

Expanded Eligibility for Third Doses of the COVID-19 Vaccine

 

On September 14, based on the recommendation of the Chief Medical Officer of Health and in alignment with NACI’s recommendation, the province will begin offering third doses of the COVID-19 vaccine to additional vulnerable populations:

  • Those undergoing active treatment for solid tumors;
  • Those who are in receipt of chimeric antigen receptor (CAR)-T-cell;
  • Those with moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome);
  • Stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome; and
  • Those undergoing active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.

 

In addition to those already eligible:

  • Transplant recipients (including solid organ transplant and hematopoietic stem cell transplants)
  • Patients with hematological cancers (examples include lymphoma, myeloma, leukemia) on active treatment (chemotherapy, targeted therapies, immunotherapy) for malignant hematologic disorders
  • Recipients of an anti-CD20 agent (e.g. rituximab, ocrelizumab, ofatumumab)

 

A third dose will help to provide individuals in these groups with an improved immune response. Individuals in these groups are eligible to receive their third dose at a minimum of eight weeks following their second dose and will be contacted by their health care provider such as their primary care provider, specialist, or their hospital specialty program. Individuals unable to receive the vaccine from their providers can ask for a form from them indicating the patient’s eligibility. The form can be taken to participating physicians who will administer the vaccine. Participating local pharmacies are now able to administer 3rd doses. To book an appointment please contact the pharmacy directly.

 

 

Immunocompromised clients who are unable to access a third-dose vaccine from their healthcare provider may attend a local pharmacy that offers COVID-19 vaccine or any of the vaccine clinics hosted by the Grey Bruce Health Unit. No appointment is necessary. For a list of locations and times of clinics visit the Grey Bruce Health Unit Vaccine Clinic Schedule. Clients must be eligible in the categories described above and must provide the written provincial documentation signed by their physician, including the physician’s CPSO number. No other document or attestation will be accepted.

 

 

For More Information:

Dr. Ian Arra, MD MSc FRCPC ACPM ABPM

Medical Officer of Health and Chief Executive Officer

 

Media inquiries should be directed to: AdminMedicalOfficer@publichealthgreybruce.on.ca

519-376-9420 or 1-800-263-3456 ext. 3940

 

| Categories: | Tags: | View Count: (1284) | Return